Heart-Guided exercise may keep aging bodies stronger

NCT ID NCT07790263

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 27, 2026 · Last updated Aug 28, 2026 · Updated 1 time

Summary

This trial tests whether a smart circuit exercise program, which uses real-time heart rate monitoring to adjust intensity, can improve health in adults aged 65 to 85. Participants do moderate exercise three times a week for about eight weeks. Researchers measure changes in heart function, blood pressure, muscle mass, balance, mood, and sleep. The goal is to see if this personalized approach helps older adults stay healthier and more active.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A moderate-intensity circuit exercise program with real-time heart rate monitoring to guide individual effort
What this could lead to
If it works, this could point toward a simple, technology-assisted exercise routine that helps older adults stay healthier and more independent.
What could go wrong
The trial is relatively small and early, and results may not apply to all older adults. Exercise always carries some risk, though the program uses monitoring to keep intensity moderate.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

256 people

The number who actually took part.

Started

May 2024

Finished

Feb 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

65 to 85 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 65 to 85 years, community-dwelling * Able to walk independently, without assistance * Able to understand study procedures in Mandarin or Taiwanese and voluntarily provide informed consent * Willing to undergo health examinations and testing, and to provide historical health examination records * Completed a health status questionnaire covering medical history, medication use, and comorbidities * Physical Activity Readiness Questionnaire Plus (PAR-Q+) results indicating suitability for exercise training (or written physician clearance obtained if any positive response) * Completed the International Physical Activity Questionnaire (IPAQ), with results not meeting the criterion for regular exercise within the past 6 months (i.e., fewer than 2 sessions/week or less than 30 minutes/session of moderate-intensity aerobic exercise) Exclusion Criteria: * Cognitive impairment or dementia precluding understanding of study procedures or compliance with test instructions * Lower-extremity fracture, joint surgery, or joint replacement within the past 3 months precluding safe completion of sit-to-stand or walking tasks * Severe joint pain precluding safe completion of baseline test movements, as assessed by study personnel * Unexplained syncope or fall history within the past 3 months, or safety concerns as assessed by study personnel * Acute illness (e.g., fever, acute infection) * Cardiac pacemaker or incompatible metal implants affecting bioelectrical impedance analysis (BIA) measurement safety * Meeting the criterion for regular exercise within the past 6 months per the International Physical Activity Questionnaire (IPAQ) (≥2 sessions/week, ≥30 minutes/session of moderate-intensity aerobic exercise) * Physical Activity Readiness Questionnaire Plus (PAR-Q+) screening results indicating unsuitability for exercise training, without written physician clearance * Unstable cardiovascular disease, including unstable angina, uncontrolled atrial or ventricular arrhythmia, uncontrolled resting sinus tachycardia (\>120 beats/min), decompensated congestive heart failure, third-degree atrioventricular block without a pacemaker, acute pericarditis or myocarditis, or recent thrombosis/thrombophlebitis * Uncontrolled diabetes (HbA1c \> 9%, resting blood glucose \> 300 mg/dL, or \> 250 mg/dL with ketosis) or poorly controlled hypertension (systolic blood pressure \> 180 mmHg or diastolic blood pressure \> 100 mmHg) * Use of medications that may interfere with muscle metabolism (e.g., high-dose corticosteroids, immunosuppressants) * Symptomatic orthostatic hypotension (blood pressure drop \> 20 mmHg) * Resting ST-segment depression \> 2 mm * Severe neurological or musculoskeletal disease precluding safe performance of study procedures, as assessed by study personnel * Currently participating in another clinical trial involving an exercise intervention * Severe anemia, acute infectious disease, or other physiological conditions deemed unsuitable for exercise training by the investigator

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Aging are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Chang Gung University

    Taoyuan, Guishan, 33371, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.